Skip to main content
Premium Trial:

Request an Annual Quote

Frank Barry, Aled Edwards, Denise Gilbert, Errol de Souza, Michael Zapata III, John Woodall, Len van Zyl, Peter Tolias, Norma Jean Nowak

Premium

Frank Barry has been named to the scientific advisory board of Toronto-based ChondroGene. He holds a PhD in biochemistry from the National University of Ireland, University College, Cork, where he also received a MSc and BSc. He is director of arthritis research at Osiris Therapeutics.

Aled Edwards has been named chief executive officer of the Structural Genomics Consortium, a UK-Canada collaboration. Edwards will continue to work with Affinium Pharmaceuticals as scientific advisor.

Denise Gilbert has been nominated to the board of directors of San Francisco-based Connetics. Gilbert previously was CEO of Entigen. She has also worked as CFO of Incyte and Affymax. She holds a PhD in cell and developmental biology from Harvard and a BS from Cornell University.

Errol de Souza was named president and chief executive officer of Cambridge, Mass.-based Archemix. De Souza previously held the same title at Synaptic Pharmaceutical.

Michael Zapata III has been named interim chief executive officer of ArrayXpress of Raleigh, NC while John Woodall has been named chief financial officer. Len van Zyl, an assistant professor at NC State University and the founder of the nascent microarray services provider, is chief science officer (see lab report, page 6). Zapata is the founder of Lips Inc., a Cary, NC-based 3D animation software company and is fellow at the Kenan Institute for Engineering, Technology & Science, and founder and former director of the Technology Education and Commercialization (TEC) program at NC State University. He is also a combat aviation officer in the North Carolina Air National Guard. He holds a master’s degree in business administration from NC State. Woodall is a CPA and a graduate of NC State. Previously, he was a partner in the accounting firm Deloitte & Touche.

Peter Tolias, former director of the Center for Applied Genomics of the Public Health Research Institute at the New Jersey Medical School in Newark, NJ, has joined Ortho-Clinical Diagnostics of Raritan, NJ as vice president for advanced research and new technology worldwide, a new position. Tolias holds a PhD and a BSc from McGill University of Montreal.

Norma Jean Nowak was named director of scientific planning for the University of Buffalo’s Center of Excellence in Bioinformatics. She also was named an associate professor of biochemistry in the school of medicine and biomedical sciences. Previously, she was director of the microarray and genomics facility, a collaborative research lab shared by Roswell Park Cancer Institute and the medical school. Nowak holds a bachelor’s in biology from Canisius College, a master’s in natural sciences and a PhD in experimental pathology from Buffalo.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.